Literature DB >> 3422644

Specificities and sensitivities of three systems for determination of antibodies to human immunodeficiency virus by electrophoretic immunoblotting.

J Blomberg1, P J Klasse.   

Abstract

Electrophoretic immunoblotting (EIB [Western blotting]) has emerged as the major method for verification of seropositivity for human immunodeficiency virus (HIV) and therefore needs to be thoroughly characterized. The specificities of three EIB systems, our own and two commercial systems, were studied with anticellular sera and serial dilutions of human sera. We demonstrated that in one system, anti-HLA classes I and II gave bands comigrating with viral proteins, which can be controlled by EIB with uninfected H9 cells. In addition, animal antisera, including anti-immunoglobulin enzyme conjugates, occasionally reacted with HIV gag proteins, necessitating appropriate controls. Whereas none of 10 blood donors reacted at the standard dilution in serum (1/100 or 1/400) in any of the three systems, 6, 1, and 2 of 10 donors reacted with p24, p55, or both at a dilution of 1/10 for the three systems tested. Thus, nonspecific reactions can arise in several ways and justify critical EIB interpretation. The sensitivity of the three systems was studied by comparative titrations and direct quantification of bound immunoglobulin G (IgG). In the titrations with all three, the minor anti-HIV bands p53 and p64, coded from pol, were often detectable in higher dilutions than were antibodies to any other HIV protein. The minimum visible amounts of IgG bound per HIV protein band estimated by extra- and interpolation in densitometric curves and liquid scintillation counting of radiolabeled patient IgG were approximately 0.1, 0.05, and 0.02 ng per band in the three systems. One of the commercial systems had both the highest sensitivity and highest specificity.

Entities:  

Mesh:

Substances:

Year:  1988        PMID: 3422644      PMCID: PMC266205          DOI: 10.1128/jcm.26.1.106-110.1988

Source DB:  PubMed          Journal:  J Clin Microbiol        ISSN: 0095-1137            Impact factor:   5.948


  18 in total

1.  Characterization of highly immunogenic p66/p51 as the reverse transcriptase of HTLV-III/LAV.

Authors:  F di Marzo Veronese; T D Copeland; A L DeVico; R Rahman; S Oroszlan; R C Gallo; M G Sarngadharan
Journal:  Science       Date:  1986-03-14       Impact factor: 47.728

2.  HLA-DR antibodies and HTLV-III antibody ELISA testing.

Authors:  S H Weiss; D L Mann; C Murray; M Popovic
Journal:  Lancet       Date:  1985-07-20       Impact factor: 79.321

3.  False-positive HTLV-III antibody tests in multitransfused patients with thalassaemia.

Authors:  V Michail-Merianou; A Tzivaras; L Piperi-Lowes; C Kattamis; V Ladis; R Papadakou-Lagogianni
Journal:  Lancet       Date:  1986-03-22       Impact factor: 79.321

4.  HLA antibodies detected by ELISA HTLV-III antibody kits.

Authors:  J B Hunter; J E Menitove
Journal:  Lancet       Date:  1985-08-17       Impact factor: 79.321

5.  Which anti-HTLV III/LAV assays for screening and confirmatory testing?

Authors:  P P Mortimer; J V Parry; J Y Mortimer
Journal:  Lancet       Date:  1985-10-19       Impact factor: 79.321

6.  HLA antibodies as a cause of false-positive reactions in screening enzyme immunoassays for antibodies to human T-lymphotropic virus type III.

Authors:  M H Sayers; P G Beatty; J A Hansen
Journal:  Transfusion       Date:  1986 Jan-Feb       Impact factor: 3.157

7.  Relative specificity of enzyme-linked immunosorbent assays for antibodies to human T-cell lymphotrophic virus, type III, and their relationship to Western blotting.

Authors:  C T Fang; F Darr; S Kleinman; R H Wehling; R Y Dodd
Journal:  Transfusion       Date:  1986 Mar-Apr       Impact factor: 3.157

8.  Importance of western blot analysis in predicting infectivity of anti-HTLV-III/LAV positive blood.

Authors:  J I Esteban; J W Shih; C C Tai; A J Bodner; J W Kay; H J Alter
Journal:  Lancet       Date:  1985-11-16       Impact factor: 79.321

9.  Quantification of immunoglobulin on electrophoretic immunoblot strips as a tool for human immunodeficiency virus serodiagnosis.

Authors:  J Blomberg; P J Klasse
Journal:  J Clin Microbiol       Date:  1988-01       Impact factor: 5.948

10.  Serological analysis of a subgroup of human T-lymphotropic retroviruses (HTLV-III) associated with AIDS.

Authors:  J Schüpbach; M Popovic; R V Gilden; M A Gonda; M G Sarngadharan; R C Gallo
Journal:  Science       Date:  1984-05-04       Impact factor: 47.728

View more
  10 in total

1.  Evaluation of a line immunoassay for the differential detection of antibodies to human immunodeficiency virus.

Authors:  R Vranckx
Journal:  Eur J Clin Microbiol Infect Dis       Date:  1990-09       Impact factor: 3.267

Review 2.  Frequency, causes, and new challenges of indeterminate results in Western blot confirmatory testing for antibodies to human immunodeficiency virus.

Authors:  Ming Guan
Journal:  Clin Vaccine Immunol       Date:  2007-04-04

3.  Quantitative western immunoblotting analysis in survey of human immunodeficiency virus-seropositive patients.

Authors:  D G Schiavini; J M Puel; S A Averous; J A Bazex
Journal:  J Clin Microbiol       Date:  1989-09       Impact factor: 5.948

4.  Quantitation of antibody reactivity to human immunodeficiency virus (type 1) proteins and glycoproteins on Western immunoblots by reflectance densitometry.

Authors:  C T Hardy; T A Damrow; G E Kenny
Journal:  J Clin Microbiol       Date:  1990-11       Impact factor: 5.948

5.  Agreement study between two laboratories of immunofluorescence as a confirmatory test for human immunodeficiency virus type 1 antibody screening.

Authors:  J Mahony; K Rosenthal; M Chernesky; S Castriciano; E Scheid; M Blajchman; D Harnish
Journal:  J Clin Microbiol       Date:  1989-06       Impact factor: 5.948

6.  Simplified and less expensive confirmatory HIV testing.

Authors:  G van der Groen; I Van Kerckhoven; G Vercauteren; P Piot
Journal:  Bull World Health Organ       Date:  1991       Impact factor: 9.408

7.  Advantages of a human immunodeficiency virus type 1 (HIV-1) persistently infected HeLa T4+ cell line for HIV-1 indirect immunofluorescence serology.

Authors:  B Forghani; J W Hurst; C S Chan
Journal:  J Clin Microbiol       Date:  1991-10       Impact factor: 5.948

8.  Evaluation of a line immunoassay for simultaneous confirmation of antibodies to HIV-1 and HIV-2.

Authors:  K Fransen; D E Pollet; M Peeters; I van Kerckhoven; G Beelaert; G Vercauteren; P Piot; G van der Groen
Journal:  Eur J Clin Microbiol Infect Dis       Date:  1991-11       Impact factor: 3.267

9.  Quantification of immunoglobulin on electrophoretic immunoblot strips as a tool for human immunodeficiency virus serodiagnosis.

Authors:  J Blomberg; P J Klasse
Journal:  J Clin Microbiol       Date:  1988-01       Impact factor: 5.948

Review 10.  Immunoblotting and dot blotting.

Authors:  D I Stott
Journal:  J Immunol Methods       Date:  1989-05-12       Impact factor: 2.303

  10 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.